RCUS logo

Arcus Biosciences (RCUS) Long Term Liabilities

Annual Total Long Term Liabilities

$449.00 M
-$46.00 M-9.29%

December 31, 2023


Summary


Performance

RCUS Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRCUSbalance sheetmetrics:

Quarterly Long Term Liabilities

$472.00 M
+$120.00 M+34.09%

September 30, 2024


Summary


Performance

RCUS Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRCUSbalance sheetmetrics:

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

RCUS Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-9.3%+0.2%
3 y3 years+202.7%+0.2%
5 y5 years+1848.1%+0.2%

RCUS Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-23.1%at low-19.4%+34.1%
5 y5-year-23.1%+2611.0%-19.4%+3630.1%
alltimeall time-23.1%+9461.3%-19.4%+3630.1%

Arcus Biosciences Long Term Liabilities History

DateAnnualQuarterly
Sep 2024
-
$472.00 M(+34.1%)
Jun 2024
-
$352.00 M(-7.9%)
Mar 2024
-
$382.00 M(-14.9%)
Dec 2023
$449.00 M(-9.3%)
$449.00 M(-4.7%)
Sep 2023
-
$471.00 M(-0.6%)
Jun 2023
-
$474.00 M(-0.2%)
Mar 2023
-
$475.00 M(-4.0%)
Dec 2022
$495.00 M(-15.2%)
$495.00 M(-4.4%)
Sep 2022
-
$517.95 M(-8.4%)
Jun 2022
-
$565.36 M(-3.5%)
Mar 2022
-
$585.59 M(+0.3%)
Dec 2021
$584.00 M
$584.00 M(+279.7%)
Sep 2021
-
$153.82 M(-6.1%)
Jun 2021
-
$163.85 M(+18.5%)
DateAnnualQuarterly
Mar 2021
-
$138.27 M(-6.8%)
Dec 2020
$148.32 M(+795.5%)
$148.32 M(+42.9%)
Sep 2020
-
$103.79 M(+720.2%)
Jun 2020
-
$12.65 M(-12.7%)
Mar 2020
-
$14.50 M(-12.4%)
Dec 2019
$16.56 M(-28.1%)
$16.56 M(-11.3%)
Sep 2019
-
$18.67 M(+18.1%)
Jun 2019
-
$15.81 M(-11.9%)
Mar 2019
-
$17.96 M(-22.1%)
Dec 2018
$23.05 M(-3.5%)
$23.05 M(-7.8%)
Sep 2018
-
$24.99 M(+9.1%)
Jun 2018
-
$22.91 M(-6.7%)
Mar 2018
-
$24.55 M(+2.7%)
Dec 2017
$23.89 M(+408.8%)
$23.89 M
Dec 2016
$4.70 M
-

FAQ

  • What is Arcus Biosciences annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Arcus Biosciences?
  • What is Arcus Biosciences annual total long term liabilities year-on-year change?
  • What is Arcus Biosciences quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Arcus Biosciences?
  • What is Arcus Biosciences quarterly long term liabilities year-on-year change?

What is Arcus Biosciences annual total long term liabilities?

The current annual total long term liabilities of RCUS is $449.00 M

What is the all time high annual total long term liabilities for Arcus Biosciences?

Arcus Biosciences all-time high annual total long term liabilities is $584.00 M

What is Arcus Biosciences annual total long term liabilities year-on-year change?

Over the past year, RCUS annual total long term liabilities has changed by -$46.00 M (-9.29%)

What is Arcus Biosciences quarterly total long term liabilities?

The current quarterly long term liabilities of RCUS is $472.00 M

What is the all time high quarterly long term liabilities for Arcus Biosciences?

Arcus Biosciences all-time high quarterly total long term liabilities is $585.59 M

What is Arcus Biosciences quarterly long term liabilities year-on-year change?

Over the past year, RCUS quarterly total long term liabilities has changed by +$1.00 M (+0.21%)